---
figid: PMC6522317__nihms-1518715-f0002
figlink: pmc/articles/PMC6522317/figure/F2/
number: F2
caption: 'Abnormally glycosylated MPL and mutant CALR C-domain could be used as a
  neoantigen targeted by T-cell Receptor Therapy (TCR). Due to aberrant CALR functions,
  CALR-mutated cells have been shown to be sensitive to BFA: Brefeldin A or other
  glycosylation inhibitors. Similarly, inhibitors targeting the JAK/STAT signaling
  (JAKi: JAK1/2 inhibitors, Erki: ERK inhibitors, MAPKi: MAPK inhibitors) pathway
  have been shown to efficiently target CALR-mutated cells. CALR instability could
  also be used to define specific and innovative therapeutic strategies for MPN patients
  harboring CALR mutations.'
pmcid: PMC6522317
papertitle: Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis.
reftext: Tiffany R. Merlinsky, et al. Clin Cancer Res. ;25(10):2956-2962.
pmc_ranked_result_index: '55419'
pathway_score: 0.9260318
filename: nihms-1518715-f0002.jpg
figtitle: Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis
year: ''
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6522317__nihms-1518715-f0002.html
  '@type': Dataset
  description: 'Abnormally glycosylated MPL and mutant CALR C-domain could be used
    as a neoantigen targeted by T-cell Receptor Therapy (TCR). Due to aberrant CALR
    functions, CALR-mutated cells have been shown to be sensitive to BFA: Brefeldin
    A or other glycosylation inhibitors. Similarly, inhibitors targeting the JAK/STAT
    signaling (JAKi: JAK1/2 inhibitors, Erki: ERK inhibitors, MAPKi: MAPK inhibitors)
    pathway have been shown to efficiently target CALR-mutated cells. CALR instability
    could also be used to define specific and innovative therapeutic strategies for
    MPN patients harboring CALR mutations.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CALR
  - TRA
  - TRB
  - TRD
  - TRG
  - JAK2
  - MPL
  - JAK3
  - FLI1
  - MAPK3
  - MAPK1
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - MAK
  - TCR
  - BFA
genes:
- word: CALR
  symbol: CALR
  source: hgnc_symbol
  hgnc_symbol: CALR
  entrez: '811'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MPL
  symbol: MPL
  source: hgnc_symbol
  hgnc_symbol: MPL
  entrez: '4352'
- word: MPL
  symbol: MPL
  source: hgnc_symbol
  hgnc_symbol: MPL
  entrez: '4352'
- word: JAKI
  symbol: JAKL
  source: hgnc_alias_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: FLI1
  symbol: FLI1
  source: hgnc_symbol
  hgnc_symbol: FLI1
  entrez: '2313'
- word: FLI1
  symbol: FLI1
  source: hgnc_symbol
  hgnc_symbol: FLI1
  entrez: '2313'
- word: FLI1
  symbol: FLI1
  source: hgnc_symbol
  hgnc_symbol: FLI1
  entrez: '2313'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: FLI1
  symbol: FLI1
  source: hgnc_symbol
  hgnc_symbol: FLI1
  entrez: '2313'
- word: МАРКі
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: MPL
  symbol: MPL
  source: hgnc_symbol
  hgnc_symbol: MPL
  entrez: '4352'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: BFA
  source: MESH
  identifier: C524118
diseases: []
figid_alias: PMC6522317__F2
redirect_from: /figures/PMC6522317__F2
figtype: Figure
---
